FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Philippe de Moerloose

Research Profile

Chemicals & Drugs

Disorders

Procedures

Concepts & Ideas

Co-author Network

Publications

TOP 3
Françoise Boehlen; Alessandro Casini; François Pugin; Philippe de Moerloose
Pulmonary embolism and fatal stroke in a patient with severe factor XI deficiency after bariatric surgery.
Françoise Boehlen; Alessandro Casini; Carlo Chizzolini; Hans Peter Kohler; Behrouz Mansouri; Guido Reber; Verena Schroeder; Philippe de Moerloose
Acquired factor XIII deficiency: a therapeutic challenge.
F Bonhomme; M Giansily-Blaizot; Charles Marc Samama; J-F Schved; Philippe de Moerloose
[Rare bleeding disorders and invasive procedures].

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Philippe de Moerloose (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Françoise Boehlen; Alessandro Casini; François Pugin; Philippe de Moerloose
Pulmonary embolism and fatal stroke in a patient with severe factor XI deficiency after bariatric surgery.
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 2013;24(3):347-50.
2013: Françoise Boehlen; Alessandro Casini; Carlo Chizzolini; Hans Peter Kohler; Behrouz Mansouri; Guido Reber; Verena Schroeder; Philippe de Moerloose
Acquired factor XIII deficiency: a therapeutic challenge.
Thrombosis and haemostasis 2013;109(3):479-87.
2013: F Bonhomme; M Giansily-Blaizot; Charles Marc Samama; J-F Schved; Philippe de Moerloose
[Rare bleeding disorders and invasive procedures].
Annales françaises d'anesthèsie et de rèanimation 2013;32(3):198-205.
2012: C Hermans; J Astermark; Philippe de Moerloose
Exposure to factor VIII and prediction of inhibitor development: exposure days vs. danger days, or both?
Journal of thrombosis and haemostasis : JTH 2012;10(10):2194-6.
2012: S Pagano; P Roux-Lombard; Nathalie Satta; E Charbonney; Philippe de Moerloose; Denis Hochstrasser; V Offord; D Werling; N Vuilleumier
Anti-apolipoprotein A-1 IgG in patients with myocardial infarction promotes inflammation through TLR2/CD14 complex.
Journal of internal medicine 2012;272(4):344-57.
2012: Yordanka Tirefort; Olivat Rakoto Alson; Philippe de Moerloose; Marguerite Neerman-Arbez
Mutation of the translation initiation codon in FGA causes congenital afibrinogenemia.
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 2012;23(6):556-8.
2012: Sophie Stoppa-Vaucher; Christophe Combescure; Philippe de Moerloose; Mirjam A Dirlewanger; Christoph A Meier; Guido Reber; Pascale Roux-Lombard; Sonja Saudan; Valerie M Schwitzgebel
Inflammatory and prothrombotic states in obese children of European descent.
Obesity (Silver Spring, Md.) 2012;20(8):1662-8.
2012: Flora Peyvandi; Angelika Batorova; Paula H B Bolton-Maggs; Philippe de Moerloose
Rare bleeding disorders.
Haemophilia : the official journal of the World Federation of Hemophilia 2012;18 Suppl 4():148-53.
2012: Jean-Luc Reny; Jean-François Schved; Isabelle Barazer; Philippe Berdagué; Henri Bounameaux; Philippe de Moerloose; Pascale Fabbro-Peray; Pierre Fontana; François Mach; Séverine Nolli; Antoine Poncet
Antiplatelet drug response status does not predict recurrent ischemic events in stable cardiovascular patients: results of the Antiplatelet Drug Resistances and Ischemic Events study.
Circulation 2012;125(25):3201-10.
2012: Yordanka Tirefort; Mario R Uhr; Marguerite Neerman-Arbez; Philippe de Moerloose
Identification of a novel F11 missense mutation (Ile463Ser) in a family with congenital factor XI deficiency.
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 2012;23(3):251-2.
2011: Anne Zufferey; Christophe Combescure; Philippe de Moerloose; Jean-Luc Reny; jean-charles sanchez; Pierre Fontana
Platelet reactivity is a stable and global phenomenon in aspirin-treated cardiovascular patients.
Thrombosis and haemostasis 2011;106(3):466-74.
2011: Nathalie Satta; Egbert Kruithof; Céline Fickentscher; Sylvie Dunoyer-Geindre; Françoise Boehlen; Guido Reber; Danielle Burger; Philippe de Moerloose
Toll-like receptor 2 mediates the activation of human monocytes and endothelial cells by antiphospholipid antibodies.
Blood 2011;117(20):5523-31.
2011: Emmanuel Levrat; Imad Aboukhamis; Philippe de Moerloose; Jaafar Farho; Sahar Chamaa; Guido Reber; Alexandre Fort; Marguerite Neerman-Arbez
A novel frameshift mutation in FGA (c.1846 del A) leading to congenital afibrinogenemia in a consanguineous Syrian family.
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 2011;22(2):148-50.
2011: Philippe de Moerloose; Lucia Mazzolai; Henri Bounameaux
[Why read the articles in this issue of Angiology and Hemostasis].
Revue médicale suisse 2011;7(281):331-2.
2010: Pierre Fontana; P Berdagué; C Castelli; S Nolli; I Barazer; P Fabbro-Peray; J-F Schved; Henri Bounameaux; François Mach; Philippe de Moerloose; J-L Reny
Clinical predictors of dual aspirin and clopidogrel poor responsiveness in stable cardiovascular patients from the ADRIE study.
Journal of thrombosis and haemostasis : JTH 2010;8(12):2614-23.
2010: Philippe de Moerloose; Guido Reber; J Musial; J Arnout
Analytical and clinical performance of a new, automated assay panel for the diagnosis of antiphospholipid syndrome.
Journal of thrombosis and haemostasis : JTH 2010;8(7):1540-6.
2010: Krystyna Zawilska; Anetta Undas; Richard J Fish; Lucyna Molendowicz-Portala; Philippe de Moerloose; Marguerite Neerman-Arbez
Characterisation of a novel nonsense mutation in FGG (Fibrinogen Poznan) causing hypofibrinogenaemia with a mild bleeding tendency.
Thrombosis and haemostasis 2010;103(3):677-9.
2010: Magy Abdel Wahab; Philippe de Moerloose; Richard J Fish; Marguerite Neerman-Arbez
Identification and functional characterization of a novel nonsense mutation in FGA accounting for congenital afibrinogenemia in six Egyptian patients.
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 2010;21(2):164-7.
2010: Pierre Fontana; Robert F Bonvini; Marco Roffi; Françoise Boehlen; Guido Reber; Philippe de Moerloose; Jean-Luc Reny
[Evaluating the biological efficacy of clopidogrel: genotype or phenotype?].
Revue médicale suisse 2010;6(235):302-5.
2010: Philippe de Moerloose; Yordanka Tirefort-Dimitrova; Franziska Noger; Rachel Spycher-Elbes; Françoise Boehlen
[Antiphospholipid syndrome: much new data].
Revue médicale suisse 2010;6(235):298-301.
2010: Grigorios Notaridis; Liliane Gschwind; Philippe de Moerloose; Françoise Boehlen
[Introduction of acenocoumarol using an algorithm for prescription].
Revue médicale suisse 2010;6(235):292, 294-7.
2010: Henri Bounameaux; Philippe de Moerloose; Lucia Mazzolai
[Carotid stents: role of evidence-based medicine!].
Revue médicale suisse 2010;6(235):275-6.
2010: Philippe de Moerloose; Françoise Boehlen; Marguerite Neerman-Arbez
Fibrinogen and the risk of thrombosis.
Seminars in thrombosis and hemostasis 2010;36(1):7-17.
2010: Marc Blondon; Arnaud Perrier; MATHIEU NENDAZ; Marc Righini; Françoise Boehlen; Michel Boulvain; Philippe de Moerloose
Thromboprophylaxis with low-molecular-weight heparin after cesarean delivery.
Thrombosis and haemostasis 2010;103(1):129-37.
2009: H Robert-Ebadi; Philippe de Moerloose; M El Khorassani; M El Khattab; Marguerite Neerman-Arbez
A novel frameshift mutation in FGA accounting for congenital afibrinogenemia predicted to encode an aberrant peptide terminating 158 amino acids downstream.
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 2009;20(5):385-7.
2009: Joanna Zdziarska; Anetta Undas; Joanna Basa; Teresa Iwaniec; Aleksander B Skotnicki; Philippe de Moerloose; Marguerite Neerman-Arbez
Severe bleeding and miscarriages in a hypofibrinogenemic woman heterozygous for the gamma Ala82Gly mutation.
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 2009;20(5):374-6.
2009: Philippe de Moerloose; Emmanuel Levrat; Pierre Fontana; Françoise Boehlen
Diagnosis of mild bleeding disorders.
Swiss medical weekly 2009;139(23-24):327-32.
2009: Philippe de Moerloose; Marguerite Neerman-Arbez
Congenital fibrinogen disorders.
Seminars in thrombosis and hemostasis 2009;35(4):356-66.
2009: Laurent Spahr; Françoise Boehlen; Philippe de Moerloose; Antoine Hadengue
Anticoagulants in portal vein thrombosis: don't be so shy!
Blood 2009;113(20):5031-2; author reply 5032.
2009: Anetta Undas; Joanna Zdziarska; Teresa Iwaniec; Ewa Stepien; Aleksander B Skotnicki; Philippe de Moerloose; Marguerite Neerman-Arbez
Fibrinogen Krakow: a novel hypo/dysfibrinogenemia mutation in fibrinogen gamma chain (Asn325Ile) affecting fibrin clot structure and function.
Thrombosis and haemostasis 2009;101(5):975-6.
2009: Anna Cavazzana; Vittorio Pengo; Marta Tonello; Franco Noventa; Claudia Grossi; Maria Orietta Borghi; Philippe de Moerloose; Guido Reber; Amelia Ruffatti
Anti-beta(2)-glycoprotein I ELISA assay: the influence of different antigen preparations.
Thrombosis and haemostasis 2009;101(4):789-91.
2009: Lucia Mazzolai; Hayoz Bounameaux; Philippe de Moerloose; Daniel Hayoz
[Angiography: need for a multidisciplinary approach].
Revue médicale suisse 2009;5(189):291-2.
2009: Philippe de Moerloose; Pierre Fontana; Françoise Boehlen
[A reference to know: the 2008 Chest Supplement on antithrombotic agents].
Revue médicale suisse 2009;5(186):110-3.
2009: Philippe de Moerloose; Françoise Boehlen
Blood coagulation and fibrinolysis: mechanisms of thrombosis.
Handbook of clinical neurology 2009;92():239-46.
2008: Nathalie Satta; Egbert Kruithof; Guido Reber; Philippe de Moerloose
Induction of TLR2 expression by inflammatory stimuli is required for endothelial cell responses to lipopeptides.
Molecular immunology 2008;46(1):145-57.
2008: Helia Robert-Ebadi; Agnès Le Querrec; Philippe de Moerloose; Sylvie Gandon-Laloum; Annie Borel-Derlon; Marguerite Neerman-Arbez
A novel Asp344Val substitution in the fibrinogen gamma chain (fibrinogen Caen) causes dysfibrinogenemia associated with thrombosis.
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 2008;19(7):697-9.
2008: Philippe de Moerloose; Gualtiero Palareti; carlos aguilar; Cristina Legnani; Guido Reber; Dirk Peetz
A multicenter evaluation of a new quantitative highly sensitive D-dimer assay for exclusion of venous thromboembolism.
Thrombosis and haemostasis 2008;100(3):505-12.
2008: Philippe de Moerloose; Marguerite Neerman-Arbez
Treatment of congenital fibrinogen disorders.
Expert opinion on biological therapy 2008;8(7):979-92.
2008: Marc Righini; Arnaud Perrier; Philippe de Moerloose; Henri Bounameaux
D-Dimer for venous thromboembolism diagnosis: 20 years later.
Journal of thrombosis and haemostasis : JTH 2008;6(7):1059-71.
2008: Guido Reber; Françoise Boehlen; Philippe de Moerloose
Technical aspects in laboratory testing for antiphospholipid antibodies: is standardization an impossible dream?
Seminars in thrombosis and hemostasis 2008;34(4):340-6.
2008: Jean-Luc Reny; Isabelle Quéré; Philippe de Moerloose; Pierre Fontana
Aspirin response variability assessed with the PFA-100 device.
Thrombosis and haemostasis 2008;99(5):968-9; author reply 969.
2008: Sylvie Dunoyer-Geindre; Françoise Boehlen; Remi Favier; Denis Wahl; Jacek Musial; Wolfgang C. Korte; Nathalie Satta; Egbert Kruithof; Philippe de Moerloose
Endothelial cell activation by immunoglobulins from patients with immune thrombocytopenic purpura or with antiphospholipid syndrome.
Haematologica 2008;93(4):635-6.
2008: Jean-Luc Reny; Philippe de Moerloose; Michel Dauzat; Pierre Fontana
Use of the PFA-100 closure time to predict cardiovascular events in aspirin-treated cardiovascular patients: a systematic review and meta-analysis.
Journal of thrombosis and haemostasis : JTH 2008;6(3):444-50.
2008: Françoise Boehlen; Franziska Noger; Philippe de Moerloose
[What is the role for the non-specialist physician in the care of patients with hemophilia?].
Revue médicale suisse 2008;4(143):328-32, 334-5.
2008: Philippe de Moerloose; Lucia Mazzolai; Henri Bounameaux
[Patient education and illiteracy in Switzerland].
Revue médicale suisse 2008;4(143):323-4.
2008: Beat Nyfeler; Yukiko Kamiya; Françoise Boehlen; Kazuo Yamamoto; Koichi Kato; Philippe de Moerloose; Hans-Peter Hauri; Marguerite Neerman-Arbez
Deletion of 3 residues from the C-terminus of MCFD2 affects binding to ERGIC-53 and causes combined factor V and factor VIII deficiency.
Blood 2008;111(3):1299-301.
2008: Philippe de Moerloose; Claude Négrier
Preventing and treating bleeding complications: new insights into therapeutic options.
Thrombosis research 2008;122 Suppl 2():S1-2.
2007: Claire Bounameaux; Françoise Boehlen; Aurélie Membré; Daniel Genné; Claire Pouplard; Véronique Regnault; Philippe de Moerloose
Heparin-induced thrombocytopenia associated with interleukin-8-dependent platelet activation in a patient with antiphospholipid syndrome.
European journal of haematology 2007;79(6):550-3.
2007: Pierre Fontana; Jean-Sébastien Hulot; Philippe de Moerloose; Pascale Gaussem
Influence of CYP2C19 and CYP3A4 gene polymorphisms on clopidogrel responsiveness in healthy subjects.
Journal of thrombosis and haemostasis : JTH 2007;5(10):2153-5.
2007: Patrick R Benusiglio; Jules Desmeules; Philippe de Moerloose; Pierre Dayer
[Oral anticoagulation and pharmacogenetics: importance in the clinical setting].
Revue médicale suisse 2007;3(124):2030, 2033-4, 2036.
2007: Anna Cavazzana; Amelia Ruffatti; Marta Tonello; Maria Bortolati; Philippe de Moerloose; Guido Reber
An analysis of experimental conditions influencing the anti-beta2-glycoprotein I ELISA assay results.
Annals of the New York Academy of Sciences 2007;1109():484-92.
2007: Marguerite Neerman-Arbez; Philippe de Moerloose
Mutations in the fibrinogen gene cluster accounting for congenital afibrinogenemia: an update and report of 10 novel mutations.
Human mutation 2007;28(6):540-53.
2007: Philippe de Moerloose; Françoise Boehlen
Inherited thrombophilia in arterial disease: a selective review.
Seminars in hematology 2007;44(2):106-13.
2007: Nathalie Satta; Sylvie Dunoyer-Geindre; Guido Reber; Richard J Fish; Françoise Boehlen; Egbert Kruithof; Philippe de Moerloose
The role of TLR2 in the inflammatory activation of mouse fibroblasts by human antiphospholipid antibodies.
Blood 2007;109(4):1507-14.
2007: Henri Bounameaux; Philippe de Moerloose; Daniel Hayoz
[Peripheric arteriopathy: focus in 2007].
Revue médicale suisse 2007;3(97):323.
2007: Sylvie Dunoyer-Geindre; Brenda R Kwak; Graziano Pelli; Isabelle Roth; Nathalie Satta; Richard J Fish; Guido Reber; François Mach; Egbert Kruithof; Philippe de Moerloose
Immunization of LDL receptor-deficient mice with beta2-glycoprotein 1 or human serum albumin induces a more inflammatory phenotype in atherosclerotic plaques.
Thrombosis and haemostasis 2007;97(1):129-38.
2006: Sophie Waldvogel Abramowski; Françoise Boehlen; Guido Reber; Philippe de Moerloose
Discrepancy between capillary and venous International Normalised Ratio (INR) in a patient on vitamin-K antagonist: potentially serious clinical consequences.
Thrombosis and haemostasis 2006;96(5):688-9.
2006: Paolo Merlani; Catherine Chenaud; Silvia R Cottini; Guido Reber; Philippe Garnerin; Philippe de Moerloose; Bara Ricou
Point of care management of heparin administration after heart surgery: A randomized, controlled trial.
Intensive care medicine 2006;32(9):1357-64.
2006: Marc Righini; Françoise Boehlen; Salah Gueddi; Grégoire LE GAL; Philippe de Moerloose
Extensive thromboembolic event as initial presentation of monoclonal gammopathy of undetermined significance.
Thrombosis and haemostasis 2006;96(1):93-4.
2006: Philippe de Moerloose; Charles Marc Samama; Serge Motte
Management of venous thromboembolism.
Canadian journal of anaesthesia = Journal canadien d'anesthésie 2006;53(6 Suppl):S80-8.
2006: Joanne Guay; Philippe de Moerloose; Dominique Lasne
Minimizing perioperative blood loss and transfusions in children.
Canadian journal of anaesthesia = Journal canadien d'anesthésie 2006;53(6 Suppl):S59-67.
2006: Jean-François Hardy; Philippe de Moerloose; Charles Marc Samama
Massive transfusion and coagulopathy: pathophysiology and implications for clinical management.
Canadian journal of anaesthesia = Journal canadien d'anesthésie 2006;53(6 Suppl):S40-58.
2006: Roula A Farah; Philippe de Moerloose; Isabelle Bouchardy; Michael Morris; Wadad Barakat; Alain E Sayad; Marguerite Neerman-Arbez
Combined factor V - factor VIII deficiency (F5F8D): compound heterozygosity for two novel truncating mutations in LMAN1 in a consanguineous patient.
Thrombosis and haemostasis 2006;95(5):893-5.
2006: Pierre Fontana; S Nolli; Guido Reber; Philippe de Moerloose
Biological effects of aspirin and clopidogrel in a randomized cross-over study in 96 healthy volunteers.
Journal of thrombosis and haemostasis : JTH 2006;4(4):813-9.
2006: Piet Meijer; Frits Haverkate; Cornelis Kluft; Philippe de Moerloose; Bert Verbruggen; Michael Spannagl
A model for the harmonisation of test results of different quantitative D-dimer methods.
Thrombosis and haemostasis 2006;95(3):567-72.
2005: Jan Jacques Michiels; Gualtiero Palareti; Philippe de Moerloose
Fibrin D-dimer testing for venous and arterial thrombotic disease.
Seminars in vascular medicine 2005;5(4):311-4.
2005: Dung Vu; Corinne Di Sanza; Dorothée Caille; Philippe de Moerloose; Holger Scheib; Paolo Meda; Marguerite Neerman-Arbez
Quality control of fibrinogen secretion in the molecular pathogenesis of congenital afibrinogenemia.
Human molecular genetics 2005;14(21):3271-80.
2005: Jean-François Hardy; Philippe de Moerloose; Charles Marc Samama
The coagulopathy of massive transfusion.
Vox sanguinis 2005;89(3):123-7.
2005: Guido Reber; Angela Tincani; Marielle Sanmarco; Philippe de Moerloose; Marie-Claire Boffa
Variability of anti-beta2 glycoprotein I antibodies measurement by commercial assays.
Thrombosis and haemostasis 2005;94(3):665-72.
2005: Dung Vu; Philippe de Moerloose; A Batorova; J Lazur; L Palumbo; Marguerite Neerman-Arbez
Hypofibrinogenaemia caused by a novel FGG missense mutation (W253C) in the gamma chain globular domain impairing fibrinogen secretion.
Journal of medical genetics 2005;42(9):e57.
2005: F Mach; D Senouf; Pierre Fontana; Françoise Boehlen; Guido Reber; Y Daali; Philippe de Moerloose; U Sigwart
Not all statins interfere with clopidogrel during antiplatelet therapy.
European journal of clinical investigation 2005;35(8):476-81.
2005: Véronique Regnault; Françoise Boehlen; H Ozsahin; Denis Wahl; P G de Groot; Thomas Lecompte; Philippe de Moerloose
Anti-protein S antibodies following a varicella infection: detection, characterization and influence on thrombin generation.
Journal of thrombosis and haemostasis : JTH 2005;3(6):1243-9.
2005: Myrna Germanos-Haddad; Philippe de Moerloose; Françoise Boehlen; Flora Peyvandi; Marguerite Neerman-Arbez
Homozygosity for a Thr575Met missense mutation in the catalytic domain associated with factor XI deficiency.
Haematologica 2005;90(3):418-9.
2005: Sylvie Dunoyer-Geindre; Yordanka Dimitrova; Richard J Fish; Nathalie Satta; Guido Reber; Egbert Kruithof; Philippe de Moerloose
Fluvastatin increases the expression of adhesion molecules, monocyte chemoattractant protein-1 and tissue factor in HUVEC stimulated by patient IgG fractions containing antiphospholipid antibodies.
Thrombosis and haemostasis 2005;93(2):339-45.
2005: Philippe de Moerloose; Henri Bounameaux; P H Wells
D-dimer testing and venous thromboembolism: four view points.
Journal of thrombosis and haemostasis : JTH 2005;3(2):380-2.
2005: Manuella Epiney; Françoise Boehlen; Michel Boulvain; Guido Reber; Eric Antonelli; M Morales; Olivier Irion; Philippe de Moerloose
D-dimer levels during delivery and the postpartum.
Journal of thrombosis and haemostasis : JTH 2005;3(2):268-71.
2005: Françoise Boehlen; Manuella Epiney; Michel Boulvain; Olivier Irion; Philippe de Moerloose
[Changes in D-dimer levels during pregnancy and the postpartum period: results of two studies].
Revue médicale suisse 2005;1(4):296-8.
2005: Salah Gueddi; Françoise Boehlen; D de Ziegler; Philippe de Moerloose
[Menorrhagia and hemostatic abnormalities: diagnosis and treatment].
Revue médicale suisse 2005;1(4):279-82.
2005: Françoise Boehlen; Guido Reber; Philippe de Moerloose
Agreement of a new whole-blood PT/INR test using capillary samples with plasma INR determinations.
Thrombosis research 2005;115(1-2):131-4.
2004: Marc Righini; Drahomir Aujesky; Pierre-Marie Roy; Jacques Cornuz; Philippe de Moerloose; Henri Bounameaux; Arnaud Perrier
Clinical usefulness of D-dimer depending on clinical probability and cutoff value in outpatients with suspected pulmonary embolism.
Archives of internal medicine 2004;164(22):2483-7.
2004: Nicolas Vuilleumier; Guido Reber; Richard James; Danielle Burger; Philippe de Moerloose; Jean-Michel Dayer; Pascale Roux-Lombard
Presence of autoantibodies to apolipoprotein A-1 in patients with acute coronary syndrome further links autoimmunity to cardiovascular disease.
Journal of autoimmunity 2004;23(4):353-60.
2004: Marguerite Neerman-Arbez; Myrna Germanos-Haddad; Konstantinos Tzanidakis; Dung Vu; Samuel Deutsch; Armelle David; Michael Morris; Philippe de Moerloose
Expression and analysis of a split premature termination codon in FGG responsible for congenital afibrinogenemia: escape from RNA surveillance mechanisms in transfected cells.
Blood 2004;104(12):3618-23.
2004: Guido Reber; Angela Tincani; Marielle Sanmarco; Philippe de Moerloose; Marie-Claire Boffa
Proposals for the measurement of anti-beta2-glycoprotein I antibodies. Standardization group of the European Forum on Antiphospholipid Antibodies.
Journal of thrombosis and haemostasis : JTH 2004;2(10):1860-2.
2004: Sylvie Dunoyer-Geindre; Egbert Kruithof; Françoise Boehlen; N Satta-Poschung; Guido Reber; Philippe de Moerloose
Aspirin inhibits endothelial cell activation induced by antiphospholipid antibodies.
Journal of thrombosis and haemostasis : JTH 2004;2(7):1176-81.
2004: Philippe de Moerloose; Guido Reber
Antiphospholipid antibodies: do we still need to perform anticardiolipin ELISA assays?
Journal of thrombosis and haemostasis : JTH 2004;2(7):1071-3.
2004: Guido Reber; Henri Bounameaux; Arnaud Perrier; Philippe de Moerloose
A new rapid point-of-care D-dimer enzyme-linked immunosorbent assay (Stratus CS D-dimer) for the exclusion of venous thromboembolism.
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 2004;15(5):435-8.
2004: Jean-Michel Gaspoz; Philippe de Moerloose
Aspirin or clopidogrel for secondary prevention of cardiovascular events: is there a winner?
The American journal of medicine 2004;116(12):850-2.
2004: Denis Wahl; Véronique Regnault; Philippe de Moerloose; Thomas Lecompte
Antiphospholipid antibodies and risk for recurrent vascular events.
JAMA : the journal of the American Medical Association 2004;291(22):2701-2; author reply 2702-3.
2004: Henri Bounameaux; Philippe de Moerloose
Is laboratory monitoring of low-molecular-weight heparin therapy necessary? No.
Journal of thrombosis and haemostasis : JTH 2004;2(4):551-4.
2004: Jean-François Hardy; Philippe de Moerloose; Marc Samama
Massive transfusion and coagulopathy: pathophysiology and implications for clinical management.
Canadian journal of anaesthesia = Journal canadien d'anesthésie 2004;51(4):293-310.
2004: Philippe de Moerloose; Myrna Germanos-Haddad; Françoise Boehlen; Marguerite Neerman-Arbez
Severe factor XI deficiency in a Lebanese family: identification of a novel missense mutation (Trp501Cys) in the catalytic domain.
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 2004;15(3):269-72.
2004: Françoise Boehlen; Michel Ange Morales; Pierre Fontana; Bara Ricou; Olivier Irion; Philippe de Moerloose
Prolonged treatment of massive postpartum haemorrhage with recombinant factor VIIa: case report and review of the literature.
BJOG : an international journal of obstetrics and gynaecology 2004;111(3):284-7.
2004: Guido Reber; Philippe de Moerloose
Anti-beta2-glycoprotein I antibodies--when and how should they be measured?
Thrombosis research 2004;114(5-6):527-31.
2004: Alexandre Campanelli; Gürkan Kaya; Ayse Hulya Ozsahin; Giorgio La Scala; Cédric Jacquier; Mélanie Stauffer; Françoise Boehlen; Philippe de Moerloose; Jean-Hilaire Saurat
Purpura fulminans in a child as a complication of chickenpox infection.
Dermatology (Basel, Switzerland) 2004;208(3):262-4.
2004: Françoise Boehlen; Marlyse Bader; Philippe de Moerloose
Superficial thrombophlebitis of the chest wall associated with anticardiolipin antibodies: antiphospholipid syndrome or Mondor's disease?
Lupus 2004;13(1):70-1.
2003: Dung Vu; Paula H B Bolton-Maggs; Jeremy R Parr; Michael Morris; Philippe de Moerloose; Marguerite Neerman-Arbez
Congenital afibrinogenemia: identification and expression of a missense mutation in FGB impairing fibrinogen secretion.
Blood 2003;102(13):4413-5.
2003: Yordanka Dimitrova; Sylvie Dunoyer-Geindre; Guido Reber; François Mach; Egbert Kruithof; Philippe de Moerloose
Effects of statins on adhesion molecule expression in endothelial cells.
Journal of thrombosis and haemostasis : JTH 2003;1(11):2290-9.
2003: François Girardin; Michèle Siegenthaler; Philippe de Moerloose; Jules Desmeules
Rofecoxib interaction with oral anticoagulant acenocoumarol.
European journal of clinical pharmacology 2003;59(5-6):489-90.
2003: Philippe de Moerloose; Françoise Boehlen
Should neurologists measure D-dimer concentrations?
Lancet neurology 2003;2(2):77.
2003: Françoise Boehlen; Oana Bulla; Martine Michel; Guido Reber; Philippe de Moerloose
HPA-genotyping and antiplatelet antibodies in female blood donors.
The hematology journal : the official journal of the European Haematology Association / EHA 2003;4(6):441-4.
2003: Philippe de Moerloose; Françoise Boehlen
[Thrombophilias].
La Revue du praticien 2003;53(1):20-4.
2003: Françoise Boehlen; J F Balavoine; Philippe de Moerloose
Severe thrombocytopenic purpura due to rubella infection in a patient with systemic lupus erythematosus.
Lupus 2003;12(2):144-6.
2002: Eduardo Schiffer; Guido Reber; Philippe de Moerloose; Denis R Morel
Evaluation of unfractionated heparin and recombinant hirudin on survival in a sustained ovine endotoxin shock model.
Critical care medicine 2002;30(12):2689-99.
2002: Sylvie Dunoyer-Geindre; Philippe de Moerloose; Béatrix Galve-de Rochemonteix; Guido Reber; Egbert Kruithof
NFkappaB is an essential intermediate in the activation of endothelial cells by anti-beta(2)-glycoprotein 1 antibodies.
Thrombosis and haemostasis 2002;88(5):851-7.
2002: Guido Reber; Henri Bounameaux; Arnaud Perrier; Philippe de Moerloose
Evaluation of advanced D-dimer assay for the exclusion of venous thromboembolism.
Thrombosis research 2002;107(5):197-200.
2002: James J Goedert; M Elaine Eyster; Michael M Lederman; Titika Mandalaki; Philippe de Moerloose; Gilbert C White; Anne Angiolillo; Naomi L C Luban; Kenneth E Sherman; Marilyn J Manco-Johnson; Liliana Preiss; Cindy A Leissinger; Craig M Kessler; Alan R Cohen; Donna DiMichele; Margaret W Hilgartner; Louis M Aledort; Barbara L Kroner; Philip S Rosenberg; Angelos Hatzakis
End-stage liver disease in persons with hemophilia and transfusion-associated infections.
Blood 2002;100(5):1584-9.
2002: Guido Reber; Inger Schousboe; Angela Tincani; Marielle Sanmarco; Tanja Kveder; Philippe de Moerloose; Marie-Claire Boffa; Josiane Arvieux
Inter-laboratory variability of anti-beta2-glycoprotein I measurement. A collaborative study in the frame of the European Forum on Antiphospholipid Antibodies Standardization Group.
Thrombosis and haemostasis 2002;88(1):66-73.
2002: Philippe de Moerloose; Françoise Boehlen
Two new antithrombotic agents (fondaparinux and ximelagatran) and their implications in anesthesia.
Canadian journal of anaesthesia = Journal canadien d'anesthésie 2002;49(6):S5-10.
2002: Isabelle Quéré; Thomas V Perneger; Jacqueline Zittoun; Hélène Bellet; Jean-Christophe Gris; Jean-Pierre Daurès; Jean-François Schved; Eric Mercier; Jean-Pierre Laroche; Michel Dauzat; Henri Bounameaux; Charles Janbon; Philippe de Moerloose
Red blood cell methylfolate and plasma homocysteine as risk factors for venous thromboembolism: a matched case-control study.
Lancet 2002;359(9308):747-52.
2002: Stefano Regazzoni; Philippe de Moerloose
[Two new very promising antithrombotic agents: pentasaccharide and ximelagatran].
Revue médicale de la Suisse romande 2002;122(1):29-33.
2001: M Ferring; Guido Reber; Philippe de Moerloose; Paolo Merlani; marc diby; Bara Ricou
Point of care and central laboratory determinations of the aPTT are not interchangeable in surgical intensive care patients.
Canadian journal of anaesthesia = Journal canadien d'anesthésie 2001;48(11):1155-60.
2001: Arnaud Perrier; Nigel Howarth; Dominique Didier; Pierre Loubeyre; Pierre-François Unger; Philippe de Moerloose; Daniel O Slosman; Alain F Junod; Henri Bounameaux
Performance of helical computed tomography in unselected outpatients with suspected pulmonary embolism.
Annals of internal medicine 2001;135(2):88-97.
2001: Sylvie Dunoyer-Geindre; Egbert Kruithof; Béatrix Galve-de Rochemonteix; C Rosnoblet; Jean Gruenberg; Guido Reber; Philippe de Moerloose
Localization of beta2-glycoprotein 1 in late endosomes of human endothelial cells.
Thrombosis and haemostasis 2001;85(5):903-7.
2001: Guido Reber; Henri Bounameaux; Arnaud Perrier; Philippe de Moerloose
Performances of a new, automated latex assay for the exclusion of venous thromboembolism.
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 2001;12(3):217-20.
2001: Françoise Boehlen; M Michel; Guido Reber; Philippe de Moerloose
Analysis of platelet donors function before and after thrombapheresis using the platelet function analyzer PFA-100.
Thrombosis research 2001;102(1):49-52.
2001: Philippe de Moerloose; M Alhenc-Gelas; Françoise Boehlen; Henri Bounameaux; M Aiach
Deep venous thrombosis and thrombophilia: indications for testing and clinical implications.
Seminars in vascular medicine 2001;1(1):89-96.
2000: Philippe de Moerloose; G Reber; A Perrier; T Perneger; H Bounameaux
Prevalence of factor V Leiden and prothrombin G20210A mutations in unselected patients with venous thromboembolism.
British journal of haematology 2000;110(1):125-9.
2000: Guido Reber; J Blanchard; Henri Bounameaux; pierre j hoffmeyer; Marie José Miron; P F Leyvraz; Philippe de Moerloose
Inability of serial fibrin monomer measurements to predict or exclude deep venous thrombosis in asymptomatic patients undergoing total knee arthroplasty.
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 2000;11(3):305-8.
2000: A Bigaroni; A Perrier; Philippe de Moerloose; T Perneger; Henri Bounameaux
Risk of major bleeding in unselected patients with venous thromboembolism.
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 2000;11(2):199-202.
2000: Arnaud Perrier; Marie José Miron; Sylvie Desmarais; Philippe de Moerloose; Daniel O Slosman; Dominique Didier; Pierre-François Unger; Alain F Junod; Julie Patenaude; Henri Bounameaux
Using clinical evaluation and lung scan to rule out suspected pulmonary embolism: Is it a valid option in patients with normal results of lower-limb venous compression ultrasonography?
Archives of internal medicine 2000;160(4):512-6.
2000: Philippe de Moerloose
D-dimer assays for the exclusion of venous thromboembolism: which test for which diagnostic strategy?
Thrombosis and haemostasis 2000;83(2):180-1.
2000: Béatrix Galve-de Rochemonteix; Tetsuyuki Kobayashi; C Rosnoblet; Margaret Lindsay; Robert Parton; Guido Reber; Emmanuel de Maistre; Denis Wahl; Egbert Kruithof; Jean Gruenberg; Philippe de Moerloose
Interaction of anti-phospholipid antibodies with late endosomes of human endothelial cells.
Arteriosclerosis, thrombosis, and vascular biology 2000;20(2):563-74.
2000: Guido Reber; Philippe de Moerloose
D-dimer assays for the exclusion of venous thromboembolism.
Seminars in thrombosis and hemostasis 2000;26(6):619-24.
1999: Marc Righini; S Gerber; P Hohlfeld; Philippe de Moerloose
[Menorrhagia, hypermenorrhea and disorders of hemostasis].
Journal de gynécologie, obstétrique et biologie de la reproduction 1999;28(5):413-8.
1999: Marie José Miron; Arnaud Perrier; Henri Bounameaux; Philippe de Moerloose; Daniel O Slosman; Dominique Didier; Alain F Junod
Contribution of noninvasive evaluation to the diagnosis of pulmonary embolism in hospitalized patients.
The European respiratory journal : official journal of the European Society for Clinical Respiratory Physiology 1999;13(6):1365-70.
1999: Guido Reber; Henri Bounameaux; Arnaud Perrier; Philippe de Moerloose
Performances of the fibrin monomer test for the exclusion of pulmonary embolism in symptomatic outpatients.
Thrombosis and haemostasis 1999;81(2):221-3.
1999: Arnaud Perrier; Sylvie Desmarais; Marie José Miron; Philippe de Moerloose; Raymond Lepage; Daniel O Slosman; Dominique Didier; Pierre-François Unger; Julie Patenaude; Henri Bounameaux
Non-invasive diagnosis of venous thromboembolism in outpatients.
Lancet 1999;353(9148):190-5.
1998: Henri Bounameaux; Marie José Miron; J Blanchard; Philippe de Moerloose; pierre j hoffmeyer; P F Leyvraz
Measurement of plasma D-dimer is not useful in the prediction or diagnosis of postoperative deep vein thrombosis in patients undergoing total knee arthroplasty.
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 1998;9(8):749-52.
1998: Guido Reber; Henri Bounameaux; Arnaud Perrier; Philippe de Moerloose
Performances of a new, rapid and automated microlatex D-dimer assay for the exclusion of pulmonary embolism in symptomatic outpatients.
Thrombosis and haemostasis 1998;80(4):719-20.
1998: Isabelle Quéré; R Wutschert; Jacqueline Zittoun; Hélène Bellet; G Reber; Jean-Christophe Gris; Charles Janbon; Jean-François Schved; Philippe de Moerloose
Association of red-blood methylfolate but not plasma folate with C677T MTHFR polymorphism in venous thromboembolic disease.
Thrombosis and haemostasis 1998;80(4):707-9.
1998: Françoise Boehlen; Oana Bulla; Philippe de Moerloose
Evaluation of a new antigen capture ELISA for detection and characterization of platelet alloantibodies.
Thrombosis research 1998;92(1):27-32.
1998: Philippe de Moerloose; R Wutschert; M Heinzmann; T Perneger; G Reber; H Bounameaux
Superficial vein thrombosis of lower limbs: influence of factor V Leiden, factor II G20210A and overweight.
Thrombosis and haemostasis 1998;80(2):239-41.
1998: Joanne Guay; Yves Ozier; Philippe de Moerloose; C M Samana; Sylvain Bélisle; Jean-François Hardy
[Polytrauma and hemostatic anomalies].
Canadian journal of anaesthesia = Journal canadien d'anesthésie 1998;45(7):683-91.
1998: Guido Reber; J Amiral; Philippe de Moerloose
Modified antithrombin III levels during normal pregnancy and relationship with prothrombin fragment F1 + 2 and thrombin-antithrombin complexes.
Thrombosis research 1998;91(1):45-7.
1998: Philippe de Moerloose; J J Michiels; Henri Bounameaux
The place of D-dimer testing in an integrated approach of patients suspected of pulmonary embolism.
Seminars in thrombosis and hemostasis 1998;24(4):409-12.
1998: Philippe de Moerloose; Henri Bounameaux; P M Mannucci
Screening test for thrombophilic patients: which tests, for which patient, by whom, when, and why?
Seminars in thrombosis and hemostasis 1998;24(4):321-7.
1998: Françoise Boehlen; Cécile Kaplan; Philippe de Moerloose
Severe neonatal alloimmune thrombocytopenia due to anti-HPA-3a.
Vox sanguinis 1998;74(3):201-4.
1997: Arnaud Perrier; L Buswell; Henri Bounameaux; Dominique Didier; Alfredo Morabia; Philippe de Moerloose; Daniel O Slosman; Pierre-François Unger; Alain F Junod
Cost-effectiveness of noninvasive diagnostic aids in suspected pulmonary embolism.
Archives of internal medicine 1997;157(20):2309-16.
1997: Arnaud Perrier; Sylvie Desmarais; Catherine Goehring; Philippe de Moerloose; Alfredo Morabia; Pierre-François Unger; Daniel O Slosman; Alain F Junod; Henri Bounameaux
D-dimer testing for suspected pulmonary embolism in outpatients.
American journal of respiratory and critical care medicine 1997;156(2 Pt 1):492-6.
1997: Henri Bounameaux; Dominique Didier; O Polat; Sylvie Desmarais; Philippe de Moerloose; O Huber
Antithrombotic prophylaxis in patients undergoing laparoscopic cholecystectomy.
Thrombosis research 1997;86(3):271-3.
1997: G E Grau; Philippe de Moerloose; Oana Bulla; J Lou; Z Lei; Guido Reber; N Mili; Bara Ricou; D R Morel; P M Suter
Haemostatic properties of human pulmonary and cerebral microvascular endothelial cells.
Thrombosis and haemostasis 1997;77(3):585-90.
1996: Henri Bounameaux; Philippe de Moerloose; F P Sarasin
Optimal duration of oral anticoagulant therapy following deep vein thrombosis of lower limbs.
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 1996;7(5):507-14.
1996: Sylvie Desmarais; Philippe de Moerloose; Guido Reber; P Minazio; Arnaud Perrier; Henri Bounameaux
Resistance to activated protein C in an unselected population of patients with pulmonary embolism.
Lancet 1996;347(9012):1374-5.
1996: Arnaud Perrier; Henri Bounameaux; Alfredo Morabia; Philippe de Moerloose; Daniel O Slosman; Dominique Didier; Alain F Junod
Diagnosis of pulmonary embolism by a decision analysis-based strategy including clinical probability, D-dimer levels, and ultrasonography: a management study.
Archives of internal medicine 1996;156(5):531-6.
1996: J L Pittet; Philippe de Moerloose; Guido Reber; C Durand; C Villard; N Piga; D Rolland; S Comby; G Dupuy
VIDAS D-dimer: fast quantitative ELISA for measuring D-dimer in plasma.
Clinical chemistry 1996;42(3):410-5.
1996: J Hafner; Philippe de Moerloose; Henri Bounameaux
Oral anticoagulation alone or in combination with aspirin: risks and benefits.
VASA. Zeitschrift für Gefässkrankheiten 1996;25(1):1-12.
1996: Philippe de Moerloose; Sylvie Desmarais; Henri Bounameaux; Guido Reber; Arnaud Perrier; G Dupuy; J L Pittet
Contribution of a new, rapid, individual and quantitative automated D-dimer ELISA to exclude pulmonary embolism.
Thrombosis and haemostasis 1996;75(1):11-3.
1996: T Fuchs-Buder; Philippe de Moerloose; Bara Ricou; Guido Reber; C Vifian; Laurent Nicod; Jacques-André Romand; P M Suter
Time course of procoagulant activity and D dimer in bronchoalveolar fluid of patients at risk for or with acute respiratory distress syndrome.
American journal of respiratory and critical care medicine 1996;153(1):163-7.
1995: Guido Reber; A M Vissac; Philippe de Moerloose; Henri Bounameaux; J Amiral
A new, semi-quantitative and individual ELISA for rapid measurement of plasma D-dimer in patients suspected of pulmonary embolism.
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 1995;6(5):460-3.
1995: O Bongard; Henri Bounameaux; P A Miescher; Philippe de Moerloose
Association of anticardiolipin antibodies and abnormal nailfold capillaroscopy in patients with systemic lupus erythematosus.
Lupus 1995;4(2):142-4.
1995: Philippe de Moerloose
[Characteristics of the diagnosis and treatment of venous thrombosis. Biological monitoring of anticoagulant treatment].
Revue médicale de la Suisse romande 1995;115(4):295-6.
1995: Guido Reber; Josiane Arvieux; E Comby; D Degenne; Philippe de Moerloose; M Sanmarco; G Potron
Multicenter evaluation of nine commercial kits for the quantitation of anticardiolipin antibodies. The Working Group on Methodologies in Haemostasis from the GEHT (Groupe d'Etudes sur l'Hémostase et la Thrombose).
Thrombosis and haemostasis 1995;73(3):444-52.
1995: Stylianos Antonarakis; Haig Kazazian ; Jane Gitschier; P Hutter; Philippe de Moerloose; Michael Morris
Molecular etiology of factor VIII deficiency in hemophilia A.
Advances in experimental medicine and biology 1995;386():19-34.
1994: Judith P. Rossiter; M Young; M L Kimberland; P Hutter; Rhett P Ketterling; Jane Gitschier; J Horst; Michael Morris; D J Schaid; Philippe de Moerloose
Factor VIII gene inversions causing severe hemophilia A originate almost exclusively in male germ cells.
Human molecular genetics 1994;3(7):1035-9.
1994: Philippe de Moerloose; P Minazio; Guido Reber; Arnaud Perrier; Henri Bounameaux
D-dimer determination to exclude pulmonary embolism: a two-step approach using latex assay as a screening tool.
Thrombosis and haemostasis 1994;72(1):89-91.
1994: O Bongard; J Wicky; R Peter; S Simonovska; J J Vogel; Philippe de Moerloose; Guido Reber; H Bonameaux
D-dimer plasma measurement in patients undergoing major hip surgery: use in the prediction and diagnosis of postoperative proximal vein thrombosis.
Thrombosis research 1994;74(5):487-93.
1994: Arnaud Perrier; Henri Bounameaux; Alfredo Morabia; Philippe de Moerloose; Daniel O Slosman; Pierre-François Unger; Alain F Junod
Contribution of D-dimer plasma measurement and lower-limb venous ultrasound to the diagnosis of pulmonary embolism: a decision analysis model.
American heart journal 1994;127(3):624-35.
1994: Guido Reber; J P Roisin; M Migaud; Philippe de Moerloose
Comparison of a platelet neutralization procedure with a hexagonal phase phospholipid neutralization assay as confirmatory tests for the presence of lupus anticoagulants.
Thrombosis research 1994;73(2):131-5.
1994: Henri Bounameaux; Philippe de Moerloose; Arnaud Perrier; Guido Reber
Plasma measurement of D-dimer as diagnostic aid in suspected venous thromboembolism: an overview.
Thrombosis and haemostasis 1994;71(1):1-6.
1993: Philippe de Moerloose; D A Tsakiris
[Antiphospholipid syndrome: a new clinical entity? Part 1: antiphospholipid antibodies: specificity and methodological problems].
Schweizerische medizinische Wochenschrift 1993;123(46):2175-82.
1993: P Raimondi; O Bongard; Philippe de Moerloose; Guido Reber; F Waldvogel; Henri Bounameaux
D-dimer plasma concentration in various clinical conditions: implication for the use of this test in the diagnostic approach of venous thromboembolism.
Thrombosis research 1993;69(1):125-30.
1992: Philippe de Moerloose; O Gavillet; D Salomon; P Minazio; Guido Reber
Heparin-related activity in peripheral venous blood after percutaneous application of various glycosaminoglycan containing creams.
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 1992;3(6):827-8.
1992: E De Benedetti; Guido Reber; P A Miescher; Philippe de Moerloose
No increase of beta 2-glycoprotein I levels in patients with antiphospholipid antibodies.
Thrombosis and haemostasis 1992;68(5):624.
1992: O Bongard; Guido Reber; Henri Bounameaux; Philippe de Moerloose
Anticardiolipin antibodies in acute venous thromboembolism.
Thrombosis and haemostasis 1992;67(6):724.
1992: Henri Bounameaux; E Khabiri; O Huber; P A Schneider; D Didier; Philippe de Moerloose; Guido Reber
Value of liquid crystal contact thermography and plasma level of D-dimer for screening of deep venous thrombosis following general abdominal surgery.
Thrombosis and haemostasis 1992;67(6):603-6.
1992: Guido Reber; C Stoermann; Philippe de Moerloose; P Ruedin; M Leski
Hemostatic disturbances induced by two hollow-fiber hemodialysis membranes.
The International journal of artificial organs 1992;15(5):269-76.
1992: E De Benedetti; Laurent Nicod; Guido Reber; C Vifian; Philippe de Moerloose
Procoagulant and fibrinolytic activities in bronchoalveolar fluid of HIV-positive and HIV-negative patients.
The European respiratory journal : official journal of the European Society for Clinical Respiratory Physiology 1992;5(4):411-7.
1992: Philippe de Moerloose; E De Benedetti; Laurent Nicod; C Vifian; Guido Reber
Procoagulant activity in bronchoalveolar fluids: no relationship with tissue factor pathway inhibitor activity.
Thrombosis research 1992;65(4-5):507-18.
1992: Henri Bounameaux; A Righetti; Philippe de Moerloose; O Bongard; Guido Reber
Effects of exercise test on plasma markers of an activation of coagulation and/or fibrinolysis in patients with symptomatic or silent myocardial ischemia.
Thrombosis research 1992;65(1):27-32.
1991: J J Vogel; Guido Reber; Philippe de Moerloose
Laboratory and clinical features in systemic lupus erythematosus patients with or without anticardiolipin antibodies.
Thrombosis research 1991;62(5):545-56.
1991: Henri Bounameaux; P Cirafici; Philippe de Moerloose; P A Schneider; Daniel O Slosman; Guido Reber; Pierre-François Unger
Measurement of D-dimer in plasma as diagnostic aid in suspected pulmonary embolism.
Lancet 1991;337(8735):196-200.
1991: Henri Bounameaux; P A Schneider; Daniel O Slosman; Philippe de Moerloose; Guido Reber
[Value of the plasma measurement of D-dimers in the diagnosis of venous thromboembolism].
Journal des maladies vasculaires 1991;16(2):133-6.
1990: Philippe de Moerloose; Guido Reber; J J Vogel
Anticardiolipin antibody determination: comparison of three ELISA assays.
Clinical and experimental rheumatology 1990;8(6):575-7.
1990: Henri Bounameaux; P A Schneider; Daniel O Slosman; Philippe de Moerloose; Guido Reber
Plasma D-dimer in suspected pulmonary embolism: a comparison with pulmonary angiography and ventilation--perfusion scintigraphy.
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 1990;1(4-5):577-9.
1990: S Moll; Philippe de Moerloose; Guido Reber; J Schifferli; M Leski
Comparison of two hemodialysis membranes, polyacrylonitrile and cellulose acetate, on complement and coagulation systems.
The International journal of artificial organs 1990;13(5):273-9.
1990: Guido Reber; C Tremblet; C Bernard; B Mermillod; Philippe de Moerloose
Anticardiolipin antibodies and thrombosis: buffer's influence on the detection and quantitation of anticardiolipin antibody measured by ELISA.
Thrombosis research 1990;57(2):215-26.
1990: C Bernard; B Exquis; Guido Reber; Philippe de Moerloose
Determination of anti-cardiolipin and other antibodies in HIV-1-infected patients.
Journal of acquired immune deficiency syndromes 1990;3(5):536-9.
1989: M E Sinclair; Guido Reber; A Schweizer; Keith L Dorrington; Philippe de Moerloose; C A Bouvier; J P Gardaz
Anticoagulation by ancrod for carbon dioxide removal by extracorporeal membrane lung in the dog.
The Journal of thoracic and cardiovascular surgery 1989;97(2):275-81.
1989: Henri Bounameaux; Daniel O Slosman; Philippe de Moerloose; Guido Reber
Laboratory diagnosis of pulmonary embolism: value of increased levels of plasma D-dimer and thrombin--antithrombin III complexes.
Biomedicine & pharmacotherapy = Biomédecine & pharmacothérapie 1989;43(5):385-8.
1989: Henri Bounameaux; P A Schneider; Guido Reber; Philippe de Moerloose; B Krahenbuhl
Measurement of plasma D-dimer for diagnosis of deep venous thrombosis.
American journal of clinical pathology 1989;91(1):82-5.
1988: J J Vogel; Philippe de Moerloose; C A Bouvier; J Gaspoz; P Riant
[Prolonged anticoagulation following chlorophacinone poisoning].
Schweizerische medizinische Wochenschrift 1988;118(50):1915-7.
1988: Philippe de Moerloose; Jean-Daniel Tissot; Guido Reber; J Schifferli; J Vogel; C A Bouvier
[Acquired hemophilia. Apropos of a case report with a fatal course].
Schweizerische medizinische Wochenschrift 1988;118(42):1542-5.
1988: Henri Bounameaux; Daniel O Slosman; Philippe de Moerloose; Guido Reber
Diagnostic value of plasma D-dimer in suspected pulmonary embolism.
Lancet 1988;2(8611):628-9.
1988: Philippe de Moerloose; Guido Reber; C A Bouvier
Spuriously low levels of protein C with a Protac activation clotting assay.
Thrombosis and haemostasis 1988;59(3):543.
1988: Guido Reber; A Schweizer; Philippe de Moerloose; M E Sinclair; C A Bouvier; J P Gardaz
Comparison between a low molecular weight and standard heparin for anticoagulation during extracorporeal CO2 removal in the dog.
Thrombosis research 1988;49(2):157-68.
1987: Philippe de Moerloose; J J Vogel; Kenneth J Clemetson; J Petite; D Bienz; C A Bouvier
[Bernard-Soulier syndrome in a Swiss family].
Schweizerische medizinische Wochenschrift 1987;117(46):1817-21.
1987: Philippe de Moerloose; Guido Reber; P Vernet; P Minazio; C A Bouvier
Antithrombin III Geneva: a hereditary abnormal AT III with defective heparin cofactor activity.
Thrombosis and haemostasis 1987;57(2):154-7.